Education
About Us
Working with TipRanks
Follow Us
Oncimmune Holdings (DE:OCY)
FRANKFURT:OCY
RESEARCH TOOLSreports
OCY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.28
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$1.51M
Enterprise ValueN/A
Total Cash (Recent Filing)$911.00K
Total Debt (Recent Filing)£5.26M
Price to Earnings (P/E)1.4
Beta0.72
Next Earnings
May 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding111,773,220
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.52
Price to Sales (P/S)0.00
P/FCF Ratio-0.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oncimmune Holdings News
PremiumCompany Announcements
Oncimmune Holdings Faces Administration and Adviser Resignations
PremiumCompany Announcements
Oncimmune Holdings Announces Change in Major Shareholder Voting Rights
PremiumCompany Announcements
Oncimmune Holdings to Enter Administration and Suspend Trading
PremiumCompany Announcements
Oncimmune Holdings Secures Strong Shareholder Support at General Meeting
PremiumCompany Announcements
Oncimmune Holdings Successfully Passes AGM ResolutionsPremiumCompany Announcements
Oncimmune Seeks Strategic Partnerships Amidst Financial ChallengesPremiumCompany Announcements
Oncimmune Holdings PLC Announce Changes in Shareholder Voting Rights
PremiumCompany Announcements
Oncimmune Announces General Meeting to Approve Financial ReportOptions Prices
Currently, No data available
---
Ownership Overview
1.56% Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
98.44% Public Companies and
Individual Investors
OCY FAQ
What was Oncimmune Holdings’s price range in the past 12 months?
Oncimmune Holdings lowest stock price was $0.01 and its highest was $0.28 in the past 12 months.
What is Oncimmune Holdings’s market cap?
Oncimmune Holdings’s market cap is $1.51M.
When is Oncimmune Holdings’s upcoming earnings report date?
Oncimmune Holdings’s upcoming earnings report date is May 28, 2025 which is tomorrow.
How were Oncimmune Holdings’s earnings last quarter?
Oncimmune Holdings released its earnings results on Feb 10, 2025. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.04.
Is Oncimmune Holdings overvalued?
According to Wall Street analysts Oncimmune Holdings’s price is currently Overvalued.
Does Oncimmune Holdings pay dividends?
Oncimmune Holdings does not currently pay dividends.
What is Oncimmune Holdings’s EPS estimate?
Oncimmune Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncimmune Holdings have?
Oncimmune Holdings has 111,773,220 shares outstanding.
What happened to Oncimmune Holdings’s price movement after its last earnings report?
Oncimmune Holdings reported an EPS of -$0.04 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.211%.
Which hedge fund is a major shareholder of Oncimmune Holdings?
Currently, no hedge funds are holding shares in DE:OCY
Company Description
Oncimmune Holdings
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.
Technical Analysis
Evgen Pharma
―
Cizzle Biotechnology Holdings PLC
―
Physiomics
―
Sareum Holdings
―
Roquefort Investments PLC
―